Jump to: navigation, search
Dithranol Wiki Str.png
Clinical data
Routes of
ATC code
Legal status
Legal status
Pharmacokinetic data
Bioavailability0%, trace amounts metabolites
Protein binding0%
Metabolismabsorbed and oxidised within the skin
Elimination half-lifen/a
CAS Number
PubChem CID
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Molar mass226.227 g/mol

WikiDoc Resources for Dithranol


Most recent articles on Dithranol

Most cited articles on Dithranol

Review articles on Dithranol

Articles on Dithranol in N Eng J Med, Lancet, BMJ


Powerpoint slides on Dithranol

Images of Dithranol

Photos of Dithranol

Podcasts & MP3s on Dithranol

Videos on Dithranol

Evidence Based Medicine

Cochrane Collaboration on Dithranol

Bandolier on Dithranol

TRIP on Dithranol

Clinical Trials

Ongoing Trials on Dithranol at Clinical Trials.gov

Trial results on Dithranol

Clinical Trials on Dithranol at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Dithranol

NICE Guidance on Dithranol


FDA on Dithranol

CDC on Dithranol


Books on Dithranol


Dithranol in the news

Be alerted to news on Dithranol

News trends on Dithranol


Blogs on Dithranol


Definitions of Dithranol

Patient Resources / Community

Patient resources on Dithranol

Discussion groups on Dithranol

Patient Handouts on Dithranol

Directions to Hospitals Treating Dithranol

Risk calculators and risk factors for Dithranol

Healthcare Provider Resources

Symptoms of Dithranol

Causes & Risk Factors for Dithranol

Diagnostic studies for Dithranol

Treatment of Dithranol

Continuing Medical Education (CME)

CME Programs on Dithranol


Dithranol en Espanol

Dithranol en Francais


Dithranol in the Marketplace

Patents on Dithranol

Experimental / Informatics

List of terms related to Dithranol

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]


Dithranol (INN) or Anthralin (USAN and former BAN) is a Hydroxyanthrone, anthracene derivative, medicine applied to the skin of people with psoriasis. It is available as creams, ointment or pastes in 0.1 to 2% stengths (Dithrocream®, Micanol® and Psorlin®).


Dithranol accumulates in mitochondria where it interferes with the supply of energy to the cell, probably by the oxidation of dithranol releasing free radicals. This impedes DNA replication and so slows the excessive cell division that occurs in psoriatic plaques. In addition Dithranol may act by reducing the elevated levels of cGMP that occurs in psoriasis.

More dithranol penetrates into impaired skin in 30 minutes than into intact skin during about 16 hours. For this reason weaker 0.1-0.5% preparations are applied over night, but stronger 1-2% products are applied for between 30 minutes and one hour depending upon the formulation.

Clinical considerations

Dithranol has a slower onset of action in controlling psoriasis, typically several weeks, compared to glucocorticoid steroids, but is without the potential for rebound reaction on withdrawal. It cannot be used on the face or genitalia.

Side effects

It temporarily stains the skin a yellowy-brown and permanently stains clothing fabrics. It may cause a local burning sensation and irritation, this may be minimised by careful attention to the details of treatment and only gradually stepping up through the strengths of dithranol formulations. The surrounding skin can be protected using soft white paraffin and the treated area is covered with tube gauze.


  • Anthralin Treatment of Psoriasis The Skin Site
  • British National Formulary 45 March 2003
  • "Micanol data sheet". New Zealand Medicines and Medical Devices Safety Authority. 2 May 2001.

de:Dithranol nl:Ditranol